LifeStance Health Group Inc.

LFST | NASDAQ

Price Alert Chart Builder DCF Calculator

$12.67

+$0.10 (+0.80%)

At close: Sep 21, 2026, 4:00 PM ET

$12.58

-$0.09 (-0.71%)

Pre-market: Sep 22, 2026, 7:35 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Market Data

Market Cap $4.91B

Enterprise Value $4.89B

Beta 1.22

Average Volume 4.58M

Shares Outstanding (Diluted) 387.3M

Shares Change YoY 0.15%

Institutional Ownership 95.18%

Exchange NASDAQ

ISIN US53228F1012

Price Performance

Price Change 1M 2.0%

Price Change 3M 34.2%

Price Change 6M 90.5%

Price Change YTD 82.0%

Price Change 1Y 135.5%

Price Change 3Y 82.6%

Price Change 5Y -18.2%

1M CAGR (ann.) 16.9%

1Y CAGR (ann.) 135.9%

5Y CAGR (ann.) -3.9%

All-Time CAGR -9.8%

Valuation

PE Ratio 97.46

Forward PE 57.26

PEG Ratio 0.04

Forward PEG 2.65

PS Ratio 3.10

Forward PS 2.50

PB Ratio 3.33

P/FCF Ratio 23.40

P/Adj. FCF Ratio 35.08

P/OCF Ratio 22.23

EV/Sales 3.08

EV/EBIT 63.40

EV/EBITDA 11.81

EV/FCF 23.28

Earnings Yield 1.0%

FCF Yield 4.3%

Adj. FCF Yield 2.9%

Financial Health

Net Cash $25.28M

Total Debt $200.66M

Cash & Short-Term Investments $225.94M

Total Assets $2.18B

Current Ratio 1.38

Quick Ratio 1.38

Debt / Equity Ratio 0.14

Debt / EBITDA 0.48

Debt / FCF 0.96

OCF / Debt 1.09

Interest Coverage 7.75

Altman Z-Score 4.59

Piotroski F-Score 7

Margins & Profitability

Gross Profit Margin 33.6%

Operating Profit Margin 5.0%

EBITDA Margin 8.3%

Net Profit Margin 3.2%

FCF Margin 13.3%

Adj. FCF Margin 8.8%

SBC / Revenue 4.4%

SBC Impact (per share) -33.3%

Returns

Return on Assets 2.3%

Return on Equity 3.4%

Return on Invested Capital 3.0%

Return on Capital Employed 4.1%

Return on Tangible Assets 7.2%

Historical Growth (CAGR)

Revenue CAGR 3Y 18.2%

Revenue CAGR 5Y 24.8%

Revenue CAGR 10Y N/A

EPS CAGR 3Y 246.4%

EPS CAGR 5Y 75.2%

EPS CAGR 10Y N/A

FCF CAGR 3Y 109.4%

FCF CAGR 5Y 172.1%

FCF CAGR 10Y N/A

Analyst Forecasts

Analyst Rating Buy

Analyst Count 11

EPS Growth Next 3Y N/A

Revenue Growth Next 3Y N/A

Earnings Date Nov 4, 2026

EPS Estimate (next Q) $0.03

EPS Growth Est (next Q) 983.0%

Revenue Est (next Q) $431.36M

Revenue Growth Est (next Q) 18.6%

Fair Value Estimates

Graham Number $3.36

Graham Upside -73.5%

Lynch Fair Value $3.25

Lynch Upside -74.3%

Price Target $13.86

Price Target Upside 9.4%

Cash Flow

Operating Cash Flow $217.87M

Free Cash Flow $210.03M

Adj. Free Cash Flow $140.08M

FCF Per Share $0.55

OCF Per Share $0.57

OCF/S Ratio 13.7%

Income Statement

Revenue $1.58B

Gross Profit $409.46M

Operating Income $78.43M

EBITDA $413.98M

Net Income $50.6M

EPS (Diluted) $0.13

Revenue / Employee $185.53K

Profit / Employee $5.92K

Employees 8,542